Jiangsu Hengrui Medicine Company Description

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents.

It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products.

The company has license agreement with GSK plc to develop up to 12 innovative medicines in respiratory, immunology and inflammation, and oncology areas.

Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.

Jiangsu Hengrui Medicine Co., Ltd.

Country	China
Founded	1970
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	20,238
CEO	Ji Feng

Contact Details

Address: No. 38, Huanghe Road Lianyungang City, Liaoning Province 222000 China
Phone	86 40 0828 3900
Website	hengrui.com

Stock Details

Ticker Symbol	600276
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE0000014W7
SIC Code	2834

Key Executives

Name	Position
Piao Yang Sun	Executive Chairman of the Board
Hong Bin Dai	Executive Deputy Chairman of the Board
Kin Chun Lau	Chief Financial Officer
Jie Ping Sun	Senior Vice President and Executive Director
Dr. Lian Shan Zhang Ph.D.	Executive Vice President and Executive Director
Dr. Ningjun Jiang M.D., Ph.D.	Executive Vice President, Chief Strategy Officer and Executive Director
Xiao Han Liu	Board Secretary
Ya Ping Shen	Deputy General Manager
Cheng Liao	Deputy General Manager
Feng He	Deputy General Manager